Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy

par A. V. Grigorieva, T. N. Iureva, Ju. V. Kursakova, E. I. Ivanova, D. Yu. Samsonov, I. M. Mikhalevich
Publié 2021

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION

par S. A. Korotkikh, E. V. Bobykin, G. V. Zhiborkin, A. Y. Anashkin, A. V. Berezin
Publié 2016

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age

par Karagiannis D, Kontadakis GA, Kaprinis K, Giarmoukakis A, Georgalas I, Parikakis EA, Tsilimbaris MK
Publié 2017

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization

par Tan CS, Sadda SR
Publié 2017